Abstract:We measured the minute-to-minute respiratory quotient (RQ), total metabolic rate, and the intensity and energy cost of locomotor activity in unrestrained rats with a recently developed open-circuit metabolic device. These measures permitted calculation of the resting metabolic rate (designated métabolisme de fond or MF). Simultaneous monitoring of the meal patterns of the animals allowed correlations between MF and feeding behavior. The major hypotheses proposed to account for the onset of feeding were challen… Show more
“…In fact, metabolic heat production (VO 2 ) was suppressed in response to nicotinic acid in our study. Consistent with our finding, 200 mg/kg nicotinic acid attenuates cold-induced increases in thermogenesis in mice 52 and norepinephrine-induced 53 or spontaneous 54 thermogenesis in rats. A major factor contributing to decreased thermogenesis is suppressed feeding in mice.…”
Nicotinic acid has been used for decades for its antiatherogenic properties in humans. Its actions on lipid metabolism intersect with multiple sleep regulatory mechanisms, but its effects on sleep have never been documented. For the first time, we investigated the effects of acute systemic administration of nicotinic acid on sleep in mice. Intraperitoneal and oral gavage administration of nicotinic acid elicited robust increases in non-rapid-eye movement sleep (NREMS) and decreases in body temperature, energy expenditure and food intake. Preventing hypothermia did not affect its sleep-inducing actions suggesting that altered sleep is not secondary to decreased body temperature. Systemic administration of nicotinamide, a conversion product of nicotinic acid, did not affect sleep amounts and body temperature, indicating that it is not nicotinamide that underlies these actions. Systemic administration of monomethyl fumarate, another agonist of the nicotinic acid receptor GPR109A, fully recapitulated the somnogenic and thermoregulatory effects of nicotinic acid suggesting that they are mediated by the GPR109A receptor. The cyclooxygenase inhibitor indomethacin completely abolished the effects of nicotinic acid indicating that prostaglandins play a key role in mediating the sleep and thermoregulatory responses of nicotinic acid.
“…In fact, metabolic heat production (VO 2 ) was suppressed in response to nicotinic acid in our study. Consistent with our finding, 200 mg/kg nicotinic acid attenuates cold-induced increases in thermogenesis in mice 52 and norepinephrine-induced 53 or spontaneous 54 thermogenesis in rats. A major factor contributing to decreased thermogenesis is suppressed feeding in mice.…”
Nicotinic acid has been used for decades for its antiatherogenic properties in humans. Its actions on lipid metabolism intersect with multiple sleep regulatory mechanisms, but its effects on sleep have never been documented. For the first time, we investigated the effects of acute systemic administration of nicotinic acid on sleep in mice. Intraperitoneal and oral gavage administration of nicotinic acid elicited robust increases in non-rapid-eye movement sleep (NREMS) and decreases in body temperature, energy expenditure and food intake. Preventing hypothermia did not affect its sleep-inducing actions suggesting that altered sleep is not secondary to decreased body temperature. Systemic administration of nicotinamide, a conversion product of nicotinic acid, did not affect sleep amounts and body temperature, indicating that it is not nicotinamide that underlies these actions. Systemic administration of monomethyl fumarate, another agonist of the nicotinic acid receptor GPR109A, fully recapitulated the somnogenic and thermoregulatory effects of nicotinic acid suggesting that they are mediated by the GPR109A receptor. The cyclooxygenase inhibitor indomethacin completely abolished the effects of nicotinic acid indicating that prostaglandins play a key role in mediating the sleep and thermoregulatory responses of nicotinic acid.
“…This synergism was observed at doses of the two agents that alone did not increase food intake , indicating that sub-threshold changes in glucose and fatty acid oxidation combine to stimulate feeding. Similar results were obtained with combined administration of 2-DG and nicotinic acid, which blocks fat mobilization (Even et al 1988). In addition, parenterally-and intragastrically-administered glucose proved to be more satiating when the rate of fatty acid oxidation was high (Geary et al 1979).…”
Section: N T E R a C T I O N S B E T W E E N Fatty A C I D Oxidatiosupporting
“…More contemporary versions of hypotheses based on the same principles are those of Friedman, Tordoff, and Ramirez (1986) and of Even and Nicolaidis (1985;Even, Coulaud, & Nicolaidis, 1988). Rather than focusing on a single nutrient or energy source such as glucose or stored fat as the sole determinant of the critical error signal, they contended that energy usage, as reflected in some critical organ such as the liver or the brain, is what is important and that it is independent of the actual fuel or fuels being utilized.…”
he realization that the body actively maintains the constancy of its T internal environment was stated clearly by Claude Bernard (1878).We (D. S. R., R. J. S., and S. C. W.) would like to acknowledge the contributions of Robert Bolles during the early development of this chapter. His untimely death was a great loss. He will be missed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.